D
Deeplife
Designs and builds incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge
About Deeplife
Founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, DeepLife is a startup developing a SaaS platform for creating digital twins of cells. The company aims to address the challenge of engineering biological systems by leveraging advancements in biochemistry and the availability of large-scale quantitative cell activity data.
The platform developed by the DeepLife team utilizes deep learning algorithms on multi-omics sequencing data, along with public and private cell atlases and proprietary cell engineering tools. The primary goal is to supplement traditional in vitro testing with in silico simulations, enabling the rapid discovery of molecular triggers to engineer cell behavior efficiently.
DeepLife collaborates with biotech and pharmaceutical companies to expedite their target identification processes. The company also maintains a strong connection with the academic community through the publication of research papers and by providing open access to its platform's features and data.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Vernon, France
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 68.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Genetics and genomics, Core AI, Genome Engineering, Digital Twin, AI Drug Discovery, biotech medtech and e-health
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $10M | $40M | YZR Capital · Relyens · Beiersdorf · Groupe Prunay | ↗ |
| SEED✓Equity / VC | Sep 2022 | $6.6M | $26M | Kima Ventures · Sylvain Gariel · Entrepreneurs First · Bpifrance | ↗ |
Growth signals
Latest recorded traffic for Deeplife is 2.5K monthly website visits, down 10.7% over the last three months. Deeplife's team declined 13.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Kima Ventures
Sylvain Gariel
Entrepreneurs First
Bpifrance
Paris Business Angels
Mid Atlantic Bio Angels- DVDidier Valet
- ADAlain Decombe
Series A4 investors entered at this stage
YZR Capital
Relyens
Beiersdorf- GPGroupe Prunay
Other known investors6 additional known investors
Creative Destruction Lab
Aloe Private Equity
Future4Care
O&P Beiersdorf Venture Capital
Paris Biotech Santé
Turenne Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Deeplife on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Deeplife’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.